Testing effectiveness (Phase 2)UnknownNCT02507492
What this trial is testing
RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients
Who this might be right for
Homozygous or Compound Heterozygous POMC, LEPR or PCSK1 Gene Mutation
Charite University, Berlin, Germany 10